Case for pharmacotherapy development for underactive bladder

Urology. 2008 Nov;72(5):966-7. doi: 10.1016/j.urology.2008.04.041. Epub 2008 Sep 6.

Authors

Michael B Chancellor¹, Jonathan Kaufman

Affiliation

¹ Department of Urology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA. chancellormb@gmail.com

PMID: 18774593
DOI: 10.1016/j.urology.2008.04.041

No abstract available

MeSH terms

Cholinesterase Inhibitors / therapeutic use
Humans
Misoprostol / therapeutic use
Muscarinic Agonists / therapeutic use
Urinary Bladder Diseases / drug therapy*
Urinary Bladder Diseases / etiology
Urinary Bladder Diseases / physiopathology
Urinary Retention / drug therapy*
Urinary Retention / etiology
Urinary Retention / physiopathology

Substances

Cholinesterase Inhibitors
Muscarinic Agonists
Misoprostol